Disclosure Information In accordance with the disclosure policies of ASAM and Joint Accreditation, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all accredited continuing education activities
if suspected or confirmed, discontinue semaglutide and do not restart [1] [3] Monitoring for gallbladder disease, particularly in patients with rapid weight loss Risk of diabetic retinopathy complications in patients with type 2 diabetes Potential for acute kidney injury, especially with dehydration from gastrointestinal side effects Rare but serious hypersensitivity reactions including anaphylaxis Contraindication in patients with personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 [1] [3] Not recommended during pregnancy or breastfeeding
Can You Switch Directly from Semaglutide to Tirzepatide
The Prelaunch Event showcased the revolutionary system designed to transform health & wellness, and offer a holistic and natural approach to weight & appetite management
By weeks 3-4, measurable weight loss typically begins, as calorie intake naturally decreases
This GLP-1 pill provides a convenient alternative for patients who prefer an oral medication while still benefiting from appetite regulation and metabolic support